Literature DB >> 12609322

Cognitive and behavioral effects of antiepileptic drugs.

Daniel L. Drane1, Kimford J. Meador.   

Abstract

Multiple factors contribute to the increased risk of cognitive and emotional deficits experienced by patients with epilepsy, including both the underlying disease state from which they suffer and the psychosocial disruption in their lifestyles that their seizures can produce. While antiepileptic drugs (AEDs) have the potential to reduce such risks by reducing seizure activity, they can also compound problems by dampening neuronal excitability throughout the brain and altering underlying neurochemical systems that impact thinking and mood. Therefore, for optimal treatment of epilepsy, one must achieve a balance between adequate seizure control and minimizing the potential side effects of the employed AEDs. This requires knowledge of the specific cognitive and behavioral effects of both established newer AEDs and an understanding of the general principles governing their delivery.

Entities:  

Year:  2002        PMID: 12609322     DOI: 10.1016/s1525-5069(02)00502-9

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  14 in total

1.  Pathological uncoupling between amplitude and connectivity of brain fluctuations in epilepsy.

Authors:  Zhiqiang Zhang; Qiang Xu; Wei Liao; Zhengge Wang; Qian Li; Fang Yang; Zongjun Zhang; Yijun Liu; Guangming Lu
Journal:  Hum Brain Mapp       Date:  2015-04-16       Impact factor: 5.038

2.  Long-term evaluation of cognition after glioma surgery in eloquent areas.

Authors:  Djaina Satoer; Evy Visch-Brink; Marion Smits; Alfred Kloet; Caspar Looman; Clemens Dirven; Arnaud Vincent
Journal:  J Neurooncol       Date:  2013-10-31       Impact factor: 4.130

Review 3.  Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities.

Authors:  Martin Klein
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

4.  Exposure to Mozart music reduces cognitive impairment in pilocarpine-induced status epilepticus rats.

Authors:  Yingshou Xing; Yi Qin; Wei Jing; Yunxiang Zhang; Yanran Wang; Daqing Guo; Yang Xia; Dezhong Yao
Journal:  Cogn Neurodyn       Date:  2015-11-04       Impact factor: 5.082

Review 5.  Epilepsy, cognition and behavior.

Authors:  Sheffali Gulati; Sangeetha Yoganathan; Biswaroop Chakrabarty
Journal:  Indian J Pediatr       Date:  2014-07-31       Impact factor: 1.967

Review 6.  Cognition and resective surgery for diffuse infiltrative glioma: an overview.

Authors:  Martin Klein; Hugues Duffau; Philip C De Witt Hamer
Journal:  J Neurooncol       Date:  2012-02-24       Impact factor: 4.130

7.  The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy.

Authors:  David N Ruskin; Susan A Masino
Journal:  Front Neurosci       Date:  2012-03-26       Impact factor: 4.677

8.  A prospective study of adverse drug reactions to antiepileptic drugs in children.

Authors:  Mark Anderson; Oluwaseun Egunsola; Janine Cherrill; Claire Millward; Apostolos Fakis; Imti Choonara
Journal:  BMJ Open       Date:  2015-06-01       Impact factor: 2.692

9.  Disrupted causal connectivity in mesial temporal lobe epilepsy.

Authors:  Gong-Jun Ji; Zhiqiang Zhang; Han Zhang; Jue Wang; Dong-Qiang Liu; Yu-Feng Zang; Wei Liao; Guangming Lu
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

10.  Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.

Authors:  Daniel A Lim; Phiroz Tarapore; Edward Chang; Marlene Burt; Lenna Chakalian; Nicholas Barbaro; Susan Chang; Kathleen R Lamborn; Michael W McDermott
Journal:  J Neurooncol       Date:  2009-01-24       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.